Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Research May Aid Cancer Diagnosis
Uncategorized

Research May Aid Cancer Diagnosis

By medwebOct 1, 2003
Share
Facebook Twitter Email

October 1, 2003

Contact: Megan Fellman at (847) 491-3115 or at
fellman@northwestern.edu

Research May Aid Cancer Diagnosis

EVANSTON, ILL.— Scientists at Northwestern University have developed an ultra-sensitive technology based on gold nanoparticles and DNA that can detect prostate specific antigen (PSA) when present at extremely low levels in a blood sample. This promising new protein-detection method could be used to monitor prostate cancer patients following surgery and detect the early signs of breast cancer.

Prostate cancer in men and breast cancer in women are the second leading causes of cancer deaths in the United States. (Only lung cancer is more deadly.) The life-saving potential of early detection has been well established for years, and improved cancer screening methods have helped to reduce the threat.

The researchers have demonstrated that their method is a million times more sensitive than conventional methods, a feature that promises to change dramatically the way proteomics (the study and analysis of protein structure and function) and medical diagnostics are done. The results are published in the Sept. 26 issue of the journal Science.

“The polymerase chain reaction, which duplicates DNA so it can be analyzed, revolutionized forensics, medicine and biotechnology,” said Chad A. Mirkin, PhD, director of Northwestern’s Institute for Nanotechnology, who led the research team, “but we haven’t had anything of comparable sensitivity for proteins. Now we do. This technology will change the way we do cancer diagnostics and treatment.”

Biomarkers, like PSA, are known for hundreds of diseases. Using these protein targets, the new method could detect diseases at earlier stages than is possible now. For example, if disease should return in a prostate cancer patient after surgery, Dr. Mirkin’s method could detect the rise in PSA early on. Also, PSA is found in extremely low concentrations in breast cancer patients, requiring an ultrasensitive screening test for effective detection.

Because proteins, unlike DNA, cannot be chemically duplicated yet, the Northwestern researchers had to develop a method of signaling the presence of a protein. They chose to use DNA as their signal because it can be amplified and read using a number of methods.

Using commercially available materials, the team outfitted a magnetic microparticle and a gold nanoparticle each with the antibody of the protein target, PSA. When in solution, the antibodies “recognize” and bind to PSA, sandwiching the protein between the two particles.

The key is that attached to each tiny gold nanoparticle (just 30 nanometers in diameter) are hundreds to thousands of identical strands of DNA. Dr. Mirkin calls this “bar-code DNA” because they have designed it as a label specific to the protein target. After the “particle-protein-particle” sandwich is removed magnetically from solution, the DNA is removed from the sandwich and read using standard DNA detection methodologies.

In the experiments conducted by Dr. Mirkin’s team, the amount of PSA present was calculated based on the amount of bar-code DNA. The researchers detected approximately 20 PSA molecules in a 10-microliter sample, an illustration of the method’s extraordinary sensitivity.

“For each molecule of captured PSA, thousands of DNA strands are released, which is our way of amplifying the signal for a protein target of interest,” said Dr. Mirkin, also George B. Rathmann Professor of Chemistry. “Power exists in its simplicity. Instead of detecting PSA our method detects the DNA, which gives us a substantial increase in the signal.”

Using the new method, a test could be developed for any protein target with a known antibody. A unique “bar-code DNA” label can be created for each target. The technology could be commercially available in two years.

In addition to Dr. Mirkin, other authors on the Science paper are Jwa-Min Nam and C. Shad Thaxton, from Northwestern University. The research was supported by the Air Force Office of Scientific Research, Defense Advanced Research Projects Agency, and National Science Foundation.

Share. Facebook Twitter Email

Related Posts

Lurie Cancer Center Receives Merit Extension from NCI

Oct 20, 2021

Drug Combination May Reduce Risk of Leukemia Relapse

Mar 26, 2020

Rewriting the Role of a Transcription Factor

Mar 19, 2020

Comments are closed.

Latest News

Epigenetic Biomarkers Predict CVD Risk

Jun 28, 2022

Student Spearheads Ukraine Aid Efforts

Jun 27, 2022

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20220617_NM_0434
20220617_NM_0858
20220617_NM_0643
20220617_NM_0835
20220617_NM_0544
20220617_NM_0450
20220617_NM_0790
20220617_NM_0811
20220617_NM_0851
20220617_NM_0696
20220617_NM_0779
20220617_NM_0838

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2022 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.